Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia

被引:25
作者
Martin, TR
Calella, AM
Silva, S
Munna, E
Modena, P
Chiesa, R
Terrevazzi, S
Ruggieri, RM
Palermo, R
Piccoli, F
Confalonieri, R
Tiraboschi, P
Fragiacomo, C
Quadri, P
Lucca, U
Forloni, G
机构
[1] Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy
[2] Pio Albergo Trivulzio, Milan, Italy
[3] Univ Palermo, Ist Neuropsichiatria, Div Neurol, Palermo, Italy
[4] Osped Riuniti Bergamo, Div Neurol, Bergamo, Italy
[5] Osped Reg Beata Vergine, Serv Geriatr, Mendrisio, Switzerland
关键词
vascular dementia; Alzheimer's disease; intronic polymorphism; beta-amyloid; apolipoprotein E; alpha(1)-antichymotrypsin; presenilin; 1;
D O I
10.1159/000017245
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Apolipoprotein E (ApoE) genotypes, presenilin 1 (PS-1) and alpha(1)-antichymotrypsin (ACT) polymorphism and the association of the genotypes were examined in patients with Alzheimer's disease (AD, n = 121) or vascular dementia (VD, n = 68) in comparison with elderly controls (n = 125). The frequency of the ApoE epsilon 4 allele was significantly increased both in late-onset AD (0.35) and in VD (0.17); the frequency of ApoE epsilon 2 was significantly reduced in AD, but it was similar in VD and controls. The presence of the allele 1 of PS-1 intronic polymorphism was not associated with AD or VD and was not influenced by the ApoE genotypes. Also, the frequency of allele A of the intronic polymorphism of ACT was similar in AD, VD and controls and it was not altered by ApoE or PS-1 genotypes. The results confirm the association between ApoE epsilon 4 and AD and indicate an increase in ApoE epsilon 4 in Vd, too. A potential protective role of ApoE epsilon 2 is also suggested for late-onset AD but not for VD. No association was shown between ACT allele A and PS-1 allele 1 in AD or VD. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 27 条
[1]   IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
SELKOE, DJ ;
POTTER, H .
CELL, 1988, 52 (04) :487-501
[2]  
American-Psychiatric-Association, 1987, DIAGN STAT MAN MENT, P97
[3]   The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease [J].
Beffert, U ;
Danik, M ;
Krzywkowski, P ;
Ramassamy, C ;
Berrada, F ;
Poirier, J .
BRAIN RESEARCH REVIEWS, 1998, 27 (02) :119-142
[4]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[5]   Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease - A meta-analysis [J].
Farrer, LA ;
Cupples, LA ;
Haines, JL ;
Hyman, B ;
Kukull, WA ;
Mayeux, R ;
Myers, RH ;
PericakVance, MA ;
Risch, N ;
vanDuijn, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (16) :1349-1356
[6]   APOLIPOPROTEIN-E EPSILON-4 ALLELE IN ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA [J].
FRISONI, GB ;
CALABRESI, L ;
GEROLDI, C ;
BIANCHETTI, A ;
DACQUARICA, AL ;
GOVONI, S ;
SIRTORI, CR ;
TRABUCCHI, M ;
FRANCESCHINI, G .
DEMENTIA, 1994, 5 (05) :240-242
[7]   Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease [J].
GomezIsla, T ;
West, HL ;
Rebeck, GW ;
Harr, SD ;
Growdon, JH ;
Locascio, JJ ;
Perls, TT ;
Lipsitz, LA ;
Hyman, BT .
ANNALS OF NEUROLOGY, 1996, 39 (01) :62-70
[8]   No genetic effect of alpha(1)-antichymotrypsin in Alzheimer disease [J].
Haines, JL ;
Pritchard, ML ;
Saunders, AM ;
Schildkraut, JM ;
Growdon, JH ;
Gaskell, PC ;
Farrer, LA ;
Auerbach, SA ;
Gusella, JF ;
Locke, PA ;
Rosi, BL ;
Yamaoka, L ;
Small, GW ;
Conneally, PM ;
Roses, AD ;
PericakVance, MA .
GENOMICS, 1996, 33 (01) :53-56
[9]   APOE-ASTERISK-4-ASSOCIATED ALZHEIMERS-DISEASE RISK IS MODIFIED BY ALPHA-1-ANTICHYMOTRYPSIN POLYMORPHISM [J].
KAMBOH, MI ;
SANGHERA, DK ;
FERRELL, RE ;
DEKOSKY, ST .
NATURE GENETICS, 1995, 10 (04) :486-488
[10]   The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology [J].
Lemere, CA ;
Lopera, F ;
Kosik, KS ;
Lendon, CL ;
Ossa, J ;
Saido, TC ;
Yamaguchi, H ;
Ruiz, A ;
Martinez, A ;
Madrigal, L ;
Hincapie, L ;
Arango, JCL ;
Anthony, DC ;
Koo, EH ;
Goate, AM ;
Selkoe, DJ ;
Arango, JCV .
NATURE MEDICINE, 1996, 2 (10) :1146-1150